Aurobindo Pharma wins two awards at Global Generics & Biosimilars Awards 2019

22 Nov 2019 Evaluate

Aurobindo Pharma has won two prestigious awards at the 6th Global Generics & Biosimilars Awards 2019 for ‘Company of the Year and Acquisition of the Year’.

The company has been recognized as the Company of the Year for its outstanding development, innovation and success over the past year. The Acquisition of the Year award was given to the company following its acquisition of Sandoz Inc., USA's dermatology and oral solids businesses in the United States.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1172.30 -7.95 (-0.67%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×